Utama › Gangguan Depresi Major › Illinois › Chicago
Kajian klinikal Gangguan Depresi Major di Chicago, IL
17 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- Charter Research - Chicago, Chicago
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- Chicago Research Center, Chicago
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Mengambil pesertaFasa 3
- Northwestern University, Chicago
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 2
- Chicago Research Center, Chicago
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Mengambil pesertaFasa 3
- Rush University, Chicago
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Mengambil pesertaFasa 3
- Vanda Investigational Site, Chicago
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Mengambil pesertaFasa 2
- Draig Clinical Site, Chicago
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Mengambil peserta
- Rush University Medical Center, Chicago
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Mengambil pesertaFasa 3
- Uptown Research Institute, Chicago
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Mengambil pesertaFasa 2
- EmVenio Research, Chicago
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Mengambil pesertaFasa 3
- Clinical Research Site, Chicago
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Mengambil pesertaFasa 2
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Mengambil peserta
- University of Illinois at Chicago, Chicago
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Mengambil pesertaFasa 2
- Pillar Clinical Research LLC, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Mengambil pesertaKajian pemerhatian
- University of Chicago Medical Center, Chicago
Study of ALTO-300 in MDD
Mengambil pesertaFasa 2
- Site 310, Chicago
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Mengambil pesertaFasa 4
- Clinical Research Site, Chicago
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY37 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Tampa, FL17 kajian
- Houston, TX16 kajian
- San Diego, CA16 kajian
- Little Rock, AR14 kajian
- Orange, CA13 kajian
- Austin, TX13 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.